Zobrazeno 1 - 10 of 48 pro vyhledávání: '"Mark M. Morris"'
1
G359.97-0.038: A Hard X-Ray Filament Associated with a Supernova Shell-Molecular Cloud Interaction
Autor: William W. Craig, William W. Zhang, Fiona A. Harrison, Franz E. Bauer, Jun-Hui Zhao, Miller Goss, Charles J. Hailey, Shuo Zhang, Eric V. Gotthelf, Kaya Mori, Finn Erland Christensen, Daniel Stern, Melania Nynka, Mark M. Morris, Stephen E. Boggs, K. Perez
Publikováno v: Nynka, M, Hailey, C J, Zhang, S, Morris, M M, Zhao, J-H, Goss, M, Bauer, F E, Boggs, S E, Craig, W W, Christensen, F E & Gotthelf, E V 2015, ' G359.97-0.038: A Hard X-Ray Filament Associated with a Supernova Shell-Molecular Cloud Interaction ', Astrophysical Journal, vol. 800, no. 2, 119 . https://doi.org/10.1088/0004-637X/800/2/119
Astrophysical Journal
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
We present the first high-energy X-ray (>10 keV) observations of the non-thermal filament G359.97-0.038 using the Nuclear Spectroscopic Telescope Array (NuSTAR). This filament is one of approximately 20 X-ray filaments of unknown origin located in th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3b6e6c43d2fff01e67b59191b17d4a
https://orbit.dtu.dk/en/publications/534bb9ad-f381-446f-9ca6-24ed1902dc9c
Zobrazit plný text záznamu
4
Akademický článek
Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge.
Autor: Avey S; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Chatterjee M; Janssen Pharmaceutical Research and Development, Boston, Massachusetts, USA., Manyakov NV; Janssen Pharmaceutical Research and Development, Beerse, Belgium., Cooper P; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Sabins N; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Mosca K; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Mori S; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Baribaud F; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Morris M; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Lehar J; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Deiteren A; Janssen Pharmaceutical Research and Development, Merksem, Belgium., Cossu M; Janssen Pharmaceutical Research and Development, Leiden, The Netherlands., Smets S; Janssen Pharmaceutical Research and Development, Merksem, Belgium., Huizer T; Janssen Pharmaceutical Research and Development, Leiden, The Netherlands., Lamousé-Smith E; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Campbell K; Janssen Pharmaceutical Research and Development, Spring House, Pennsylvania, USA., Pandis I; Janssen Pharmaceutical Research and Development, London, UK.
Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Feb; Vol. 17 (2), pp. e13734.
Zobrazit plný text záznamu
5
Akademický článek
Non-local polarization alignment and control in fibers using feedback from correlated measurements of entangled photons.
Autor: Dowling E, Morris M, Baumgartner G, Roy R, Murphy TE
Publikováno v: Optics express [Opt Express] 2023 Jan 16; Vol. 31 (2), pp. 2316-2329.
Zobrazit plný text záznamu
6
Akademický článek
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.
Autor: Come JH; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Senter TJ; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Clark MP; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Court JJ; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Gale-Day Z; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Gu W; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Krueger E; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Liang J; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Morris M; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Nanthakumar S; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., O'Dowd H; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Maltais F; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Iyer G; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Andreassi J; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Boucher C; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Considine T; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Moody CS; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Taylor W; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Mohanty AK; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Huang Y; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Zuccola H; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Coll J; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Bonanno KC; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Gagnon KJ; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Gan L; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Lu F; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Gao H; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Chakilam A; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Engtrakul J; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Song B; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Crawford D; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Doyle E; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Kramer T; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Vought B; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Phillips J; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Kemper R; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Sanders M; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Swett R; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Furey B; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Winquist R; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Bunnage ME; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Jackson KL; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Charifson PS; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States., Magavi SS; Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston, Massachusetts 02210, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2021 Dec 23; Vol. 64 (24), pp. 17753-17776. Date of Electronic Publication: 2021 Nov 08.
Zobrazit plný text záznamu
7
Akademický článek
An Examination of National Cancer Risk Based on Monitored Hazardous Air Pollutants.
Autor: Weitekamp CA; Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency (U.S. EPA), Research Triangle Park, North Carolina, USA., Lein M; Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency (U.S. EPA), Research Triangle Park, North Carolina, USA.; Oak Ridge Associated Universities, Oak Ridge, Tennessee, USA., Strum M; Air Quality Assessment Division, Office of Air Quality Planning and Standards, U.S. EPA, Research Triangle Park, North Carolina, USA., Morris M; Health and Environmental Impacts Division, Office of Air Quality Planning and Standards, U.S. EPA, Research Triangle Park, North Carolina, USA., Palma T; Health and Environmental Impacts Division, Office of Air Quality Planning and Standards, U.S. EPA, Research Triangle Park, North Carolina, USA., Smith D; Health and Environmental Impacts Division, Office of Air Quality Planning and Standards, U.S. EPA, Research Triangle Park, North Carolina, USA., Kerr L; Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency (U.S. EPA), Research Triangle Park, North Carolina, USA.; Oak Ridge Associated Universities, Oak Ridge, Tennessee, USA., Stewart MJ; Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency (U.S. EPA), Research Triangle Park, North Carolina, USA.
Publikováno v: Environmental health perspectives [Environ Health Perspect] 2021 Mar; Vol. 129 (3), pp. 37008. Date of Electronic Publication: 2021 Mar 24.
Zobrazit plný text záznamu
8
Akademický článek
Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm.
Autor: Marinescu AG; Elysium Health, New York, NY, USA., Chen J; Product Safety Labs, Dayton, NJ, USA., Holmes HE; Elysium Health, New York, NY, USA., Guarente L; Elysium Health, New York, NY, USA.; Department of Biology, MIT, Cambridge, MA, USA., Mendes O; Product Safety Labs, Dayton, NJ, USA., Morris M; Elysium Health, New York, NY, USA., Dellinger RW; Elysium Health, New York, NY, USA.
Publikováno v: International journal of toxicology [Int J Toxicol] 2020 Jul/Aug; Vol. 39 (4), pp. 307-320.
Zobrazit plný text záznamu
9
Akademický článek
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.
Autor: Mehta G; Institute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK., Rousell S; Clinical Outcomes Solutions, Folkestone, UK., Burgess G; Vectura Group PLC, Chippenham, UK., Morris M; Clinical Outcomes Solutions, Folkestone, UK., Wright G; Department of Gastroenterology, Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, UK., McPherson S; Liver Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Frenette C; Department of Organ Transplantation, Scripps Green Hospital, San Diego, USA., Cave M; Department of Medicine, University of Louisville School of Medicine, Louisville, USA., Hagerty DT; Conatus Pharmaceuticals Inc., San Diego, USA., Spada A; Conatus Pharmaceuticals Inc., San Diego, USA., Jalan R; Institute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK.
Publikováno v: Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2018 Sep; Vol. 8 (3), pp. 224-234. Date of Electronic Publication: 2017 Nov 22.
Zobrazit plný text záznamu
10
Akademický článek
Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD + levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.
Autor: Dellinger RW; Elysium Health, Inc, New York, NY USA., Santos SR; Elysium Health, Inc, New York, NY USA., Morris M; Elysium Health, Inc, New York, NY USA., Evans M; 2KGK Synergize London, London, ON Canada., Alminana D; Elysium Health, Inc, New York, NY USA., Guarente L; Elysium Health, Inc, New York, NY USA.; 3Department of Biology, MIT, 77 Massachusetts avenue, 68-280, Cambridge, MA 02139 USA., Marcotulli E; Elysium Health, Inc, New York, NY USA.
Publikováno v: NPJ aging and mechanisms of disease [NPJ Aging Mech Dis] 2018 Aug 20; Vol. 4, pp. 8. Date of Electronic Publication: 2018 Aug 20 (Print Publication: 2018).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje